T. Rowe Price Health Sciences Fund I Class (THISX) Research
The fund's primary objective is to achieve long-term capital appreciation. To meet this goal, it typically invests at least 80% of its net assets (including any assets acquired through borrowing) in the common stocks of companies within the broad "health sciences" sector. This includes firms involved in the research, development, production, or distribution of products and services related to healthcare, medicine, or life sciences. While the fund maintains the flexibility to invest in companies of any size, the majority of its portfolio is expected to be allocated to large- and mid-capitalization companies.
Market snapshot
- Symbol
- THISX
- Price
- $82.52
- Day change
- -0.36%
- Market cap
- $11.1B
- 52-week range
- 74.74-96.05
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- Oakmark International R6 (OAZIX)
- Sprott Physical Gold Trust (PHYS)
- T. Rowe Price International Stock (PRITX)
- T. Rowe Price International Stock Fund Class R (RRITX)
- T. Rowe Price Retirement 2020 Fund Class R (RRTBX)
- Columbia Seligman Technology and Information Fund Class R (SCIRX)
- T. Rowe Price Mid-Cap Value Fund Advisor Class (TAMVX)
- T. Rowe Price Mid-Cap Value Fund I Class (TRMIX)
Open T. Rowe Price Health Sciences Fund I Class (THISX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.